Assignee
ADEPTHERA LLC
US·4 granted patents·4 pending applications·0 citations·filing 2017–2024
Top patents by PatentIndex Score
8 records- 0184US2025154219A1Peptide analogsADEPTHERA LLC·Filed 2024·Application pending·0 cites
- 0279US12110318B2Peptide analogsADEPTHERA LLC·Filed 2022·Granted Oct 8, 2024·0 cites·7 claims
- 0372US11390657B2Peptide analogsADEPTHERA LLC·Filed 2020·Granted Jul 19, 2022·0 cites·1 claims
- 0462US2019153059A1Peptide analogsADEPTHERA LLC·Filed 2018·Application pending·0 cites
- 0560US2022340633A1Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormonesADEPTHERA LLC·Filed 2021·Application pending·0 cites
- 0657US11034745B2Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormonesADEPTHERA LLC·Filed 2017·Granted Jun 15, 2021·0 cites·7 claims
- 0753US2020405868A1Gel-forming polypeptidesADEPTHERA LLC·Filed 2019·Application pending·0 cites
- 0847US11701409B2Dosing and use of long-acting CLR/ramp agonistsADEPTHERA LLC·Filed 2017·Granted Jul 18, 2023·0 cites·8 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →